Vaccines administered parenterally have been developed against gonadotrophin releasing hormone (GnRH) for anti-fertility and anti-cancer purposes. The aim of this study was to demonstrate whether mucosal delivery using GnRH immunogens entrapped in lipid nanoparticles (LNP) could induce anti-GnRH antibody titres. Immunogens consisting of KLH (keyhole limpet haemocyanin) conjugated to either GnRH-I or GnRH-III analogues were entrapped in LNP. Loaded non-ionic surfactant vesicles (NISV) were administered subcutaneously, while nasal delivery was achieved using NISV in xanthan gum and oral delivery using NISV containing deoxycholate (bilosomes). NISV and bilosomes had similar properties: they were spherical, in the nanometre size range, with a slightly negative zeta potential and surface properties that changed with protein loading and inclusion of xanthan gum. Following immunisation in female BALB/c mice, systemic antibody responses were similar for both GnRH-I and GnRH-III immunisation. Only nasal delivery proved to be successful in terms of producing systemic and mucosal antibodies.
|Number of pages||9|
|Journal||Nanomedicine: Nanotechnology, Biology and Medicine|
|Early online date||26 Dec 2013|
|Publication status||Published - Jul 2014|
- gonadotrophin-releasing hormone
- non-ionic surfactant vesicles
- atomic force microscopy
FingerprintDive into the research topics of 'Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles'. Together they form a unique fingerprint.
- Strathclyde Institute Of Pharmacy And Biomedical Sciences - Senior Lecturer